{"schema_version":"secwatch.filing_event.v1","accession":"0000015847-26-000009","form_type":"8-K","ticker":"BUKS","cik":"0000015847","company_name":"BUTLER NATIONAL CORP","filed_at":"2026-06-01T16:41:32+00:00","discovered_at":"2026-06-01T16:42:00.281244+00:00","generated_at":"2026-06-01T16:42:13.838539+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"CEO Christopher Reedy discloses ongoing cancer treatment; remains in role","bullets":["CEO Christopher Reedy informed employees of new medical treatment following Mayo Clinic consultations; he has continued follow-ups since 2019 cancer diagnosis.","Reedy will continue as CEO and remain actively engaged with operations, leadership team, and Board.","Executive Chairman Jeffrey D. Yowell and Lead Independent Director Joseph P. Daly expressed full Board support for Reedy.","Treatment may periodically require time away from office; executive leadership team and Board will support ongoing operations."],"urls":{"canonical":"https://secwatch.observer/filing/0000015847-26-000009","json":"https://secwatch.observer/filing/0000015847-26-000009.json","markdown":"https://secwatch.observer/filing/0000015847-26-000009.md","text":"https://secwatch.observer/filing/0000015847-26-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/15847/000001584726000009/0000015847-26-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/15847/000001584726000009/buks-20260601.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T16:42:13.838539+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001437749-26-018930","ticker":"CPSH","company_name":"CPS TECHNOLOGIES CORP/DE/","filed_at":"2026-06-01T13:35:50+00:00","headline":"CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share","event_type":"other_material","sec_items":["1.01","5.03","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018930","json":"https://secwatch.observer/filing/0001437749-26-018930.json","markdown":"https://secwatch.observer/filing/0001437749-26-018930.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/cpsh20260528_8k.htm"},"side_by_side_evidence":null},{"accession":"0001467623-26-000040","ticker":"DBX","company_name":"DROPBOX, INC.","filed_at":"2026-06-01T13:06:23+00:00","headline":"Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program","event_type":"other_material","sec_items":["1.01","2.03","7.01","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001467623-26-000040","json":"https://secwatch.observer/filing/0001467623-26-000040.json","markdown":"https://secwatch.observer/filing/0001467623-26-000040.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1467623/000146762326000040/0001467623-26-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1467623/000146762326000040/dbx-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001129928-26-000037","ticker":"ONCY","company_name":"ONCOLYTICS BIOTECH INC","filed_at":"2026-06-01T13:06:14+00:00","headline":"Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.45,"calibrated_materiality_score":0.45,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001129928-26-000037","json":"https://secwatch.observer/filing/0001129928-26-000037.json","markdown":"https://secwatch.observer/filing/0001129928-26-000037.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1129928/000112992826000037/0001129928-26-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1129928/000112992826000037/oncy-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-068614","ticker":"CLIR","company_name":"ClearSign Technologies Corp","filed_at":"2026-06-01T12:30:28+00:00","headline":"ClearSign Technologies prices 777,780-share public offering at $4.33/share for ~$3.37M gross proceeds","event_type":"other_material","sec_items":["1.01","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068614","json":"https://secwatch.observer/filing/0001104659-26-068614.json","markdown":"https://secwatch.observer/filing/0001104659-26-068614.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434524/000110465926068614/0001104659-26-068614-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434524/000110465926068614/tm2615953d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0000912767-26-000035","ticker":"UFPI","company_name":"UFP INDUSTRIES INC","filed_at":"2026-06-01T12:17:02+00:00","headline":"UFP Industries authorizes $300M share repurchase program, replacing prior authorization","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000912767-26-000035","json":"https://secwatch.observer/filing/0000912767-26-000035.json","markdown":"https://secwatch.observer/filing/0000912767-26-000035.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/912767/000091276726000035/0000912767-26-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/912767/000091276726000035/ufpi-20260529x8k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026522","ticker":"VRNO","company_name":"Verano Holdings Corp.","filed_at":"2026-06-01T11:15:33+00:00","headline":"Verano Announces 1-for-5 Reverse Stock Split, Reducing Shares to ~72.9M, to Facilitate U.S. Exchange Listing","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026522","json":"https://secwatch.observer/filing/0001493152-26-026522.json","markdown":"https://secwatch.observer/filing/0001493152-26-026522.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1848416/000149315226026522/0001493152-26-026522-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1848416/000149315226026522/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-249594","ticker":"CATX","company_name":"Perspective Therapeutics, Inc.","filed_at":"2026-06-01T10:30:22+00:00","headline":"Perspective Therapeutics updates pipeline: VMT-α-NET durable disease control; VMT01 and PSV359 progress","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-249594","json":"https://secwatch.observer/filing/0001193125-26-249594.json","markdown":"https://secwatch.observer/filing/0001193125-26-249594.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/728387/000119312526249594/0001193125-26-249594-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/728387/000119312526249594/catx-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-063110","ticker":"RDAC","company_name":"Rising Dragon Acquisition Corp.","filed_at":"2026-06-01T10:08:35+00:00","headline":"Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed","event_type":"other_material","sec_items":["1.01","5.03","5.07","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063110","json":"https://secwatch.observer/filing/0001213900-26-063110.json","markdown":"https://secwatch.observer/filing/0001213900-26-063110.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/0001213900-26-063110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/ea0292895-8k_rising.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}